Your cart is currently empty!
New Cancer Vaccine Triggers Powerful Immune Response In Nearly 99% Of Patients
An experimental vaccine targeting one of the deadliest forms of cancer has produced an encouraging result in a clinical trial, with nearly 99% of evaluated patients developing an immune response against mutations linked to pancreatic cancer. The findings have attracted attention because pancreatic cancer remains particularly difficult to treat, especially when it returns after surgery…